These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24816898)

  • 1. Enhanced creative thinking under dopaminergic therapy in Parkinson disease.
    Faust-Socher A; Kenett YN; Cohen OS; Hassin-Baer S; Inzelberg R
    Ann Neurol; 2014 Jun; 75(6):935-42. PubMed ID: 24816898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creative Thinking, Professional Artists, and Parkinson's Disease.
    Canesi M; Rusconi ML; Moroni F; Ranghetti A; Cereda E; Pezzoli G
    J Parkinsons Dis; 2016; 6(1):239-46. PubMed ID: 26639447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artistic productivity and creative thinking in Parkinson's disease.
    Canesi M; Rusconi ML; Isaias IU; Pezzoli G
    Eur J Neurol; 2012 Mar; 19(3):468-72. PubMed ID: 21981324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Dopaminergic Replacement Therapy on Creative Thinking and Insight Problem-Solving in Parkinson's Disease Patients.
    Salvi C; Leiker EK; Baricca B; Molinari MA; Eleopra R; Nichelli PF; Grafman J; Dunsmoor JE
    Front Psychol; 2021; 12():646448. PubMed ID: 33763005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creativity related to dopaminergic treatment: A multicenter study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Desojo LV
    Parkinsonism Relat Disord; 2019 Jun; 63():169-173. PubMed ID: 30824283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creativity in Parkinson's disease as a function of right versus left hemibody onset.
    Drago V; Foster PS; Skidmore FM; Heilman KM
    J Neurol Sci; 2009 Jan; 276(1-2):179-83. PubMed ID: 18952243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study.
    Erga AH; Alves G; Larsen JP; Tysnes OB; Pedersen KF
    J Parkinsons Dis; 2017; 7(1):183-191. PubMed ID: 27911342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The awakening of artistic creativity and Parkinson's disease.
    Inzelberg R
    Behav Neurosci; 2013 Apr; 127(2):256-61. PubMed ID: 23316709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
    Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
    Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients.
    Varrone A; Svenningsson P; Marklund P; Fatouros-Bergman H; Forsberg A; Halldin C; Nilsson LG; Farde L
    Synapse; 2015 Jul; 69(7):365-74. PubMed ID: 25914348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.
    Valko PO; Waldvogel D; Weller M; Bassetti CL; Held U; Baumann CR
    Eur J Neurol; 2010 Dec; 17(12):1428-36. PubMed ID: 20491889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease.
    Bellosta Diago E; Lopez Del Val LJ; Santos Lasaosa S; López Garcia E; Viloria Alebesque A
    Neurologia; 2017 Oct; 32(8):494-499. PubMed ID: 27087472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
    Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creative thinking and cognitive estimation in Parkinson's disease.
    Heldmann M; Rinckens C; Brüggemann N; Al-Khaled M; Münte TF
    Neurol Res Pract; 2024 Feb; 6(1):9. PubMed ID: 38355739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual differences in verbal creative thinking are reflected in the precuneus.
    Chen QL; Xu T; Yang WJ; Li YD; Sun JZ; Wang KC; Beaty RE; Zhang QL; Zuo XN; Qiu J
    Neuropsychologia; 2015 Aug; 75():441-9. PubMed ID: 26150204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
    Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
    J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dark side of dopaminergic therapies in Parkinson's disease: shedding light on aberrant salience.
    Poletti M
    CNS Spectr; 2018 Dec; 23(6):347-351. PubMed ID: 28264738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and the biology of creativity: lessons from Parkinson's disease.
    Lhommée E; Batir A; Quesada JL; Ardouin C; Fraix V; Seigneuret E; Chabardès S; Benabid AL; Pollak P; Krack P
    Front Neurol; 2014; 5():55. PubMed ID: 24795692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.